Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Papp

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Acta Haematologica|December 10, 2003
Search for factor V Arg306 Cambridge and Hong Kong mutations in mixed Hungarian population samplesK Komlósi, V Havasi, J Bene, et al.
Science (New York, N.Y.)|July 27, 2023
In vivo hematopoietic stem cell modification by mRNA deliveryLaura Breda, Tyler E Papp, Michael P Triebwasser, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 10, 2023
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic TropismMargaret M Billingsley, Ningqiang Gong, Alvin J Mukalel, et al.
Science (New York, N.Y.)|January 6, 2022
CAR T cells produced in vivo to treat cardiac injuryJoel G Rurik, István Tombácz, Amir Yadegari, et al.
Journal of Medicinal Chemistry|October 11, 1996
Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase by nuclear variants of mycophenolic acidP H Nelson, S F Carr, B H Devens, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 26, 2021
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)Hamideh Parhiz, Jacob S Brenner, Priyal N Patel, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic strokeJia Nong, Patrick M Glassman, Sahily Reyes-Esteves, et al.
Blood|July 1, 2024
Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapyMaxwell E Chappell, Laura Breda, Lucas Tricoli, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Lipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape Without Side EffectsSerena Omo-Lamai, Yufei Wang, Manthan N Patel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2024
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic strokeJia Nong, Patrick M Glassman, Vladimir V Shuvaev, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Acta Haematologica|December 10, 2003
Search for factor V Arg306 Cambridge and Hong Kong mutations in mixed Hungarian population samplesK Komlósi, V Havasi, J Bene, et al.
Science (New York, N.Y.)|July 27, 2023
In vivo hematopoietic stem cell modification by mRNA deliveryLaura Breda, Tyler E Papp, Michael P Triebwasser, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 10, 2023
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic TropismMargaret M Billingsley, Ningqiang Gong, Alvin J Mukalel, et al.
Science (New York, N.Y.)|January 6, 2022
CAR T cells produced in vivo to treat cardiac injuryJoel G Rurik, István Tombácz, Amir Yadegari, et al.
Journal of Medicinal Chemistry|October 11, 1996
Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase by nuclear variants of mycophenolic acidP H Nelson, S F Carr, B H Devens, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 26, 2021
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)Hamideh Parhiz, Jacob S Brenner, Priyal N Patel, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic strokeJia Nong, Patrick M Glassman, Sahily Reyes-Esteves, et al.
Blood|July 1, 2024
Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapyMaxwell E Chappell, Laura Breda, Lucas Tricoli, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Lipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape Without Side EffectsSerena Omo-Lamai, Yufei Wang, Manthan N Patel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2024
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic strokeJia Nong, Patrick M Glassman, Vladimir V Shuvaev, et al.
Pageof 11